# 49 CFR 40.177 What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?

49 CFR 40.177 What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?, “What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or…”, is a CFR section of [49 CFR Part 40, Subpart H—Split Specimen Tests](https://ontology.bommaritollc.com/id/01a0ee02-0928-7725-aab6-beebeb4a8fc8); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5>

Within: [Title 49—Transportation](https://ontology.bommaritollc.com/id/01a0ee01-fc87-759f-a3db-1bef0e04048a) › [49 CFR Subtitle A—Office of the Secretary of Transportation](https://ontology.bommaritollc.com/id/01a0ee02-0875-7711-b18b-423fd1398962) › [49 CFR Part 40—Procedures for transportation workplace drug and alcohol testing programs](https://ontology.bommaritollc.com/id/01a0ee02-1004-73d1-83af-3c072db2c118) › [49 CFR Part 40, Subpart H—Split Specimen Tests](https://ontology.bommaritollc.com/id/01a0ee02-0928-7725-aab6-beebeb4a8fc8)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 49 CFR 40.177](https://ontology.bommaritollc.com/id/01a0ee02-5bd4-752d-b70d-0721932bd884)
- `eli:cites`:
  - [49 CFR 40.85 What are the cutoff concentrations for urine drug tests?](https://ontology.bommaritollc.com/id/01a0ee02-5baf-7709-a77d-8b2fd0d8778e)
  - [49 CFR 40.87 What validity tests must laboratories conduct on primary urine specimens?](https://ontology.bommaritollc.com/id/01a0ee02-5bb1-70d8-b926-bbbd0fba6d2d)
  - [49 CFR 40.91 What are the cutoff concentrations for oral fluid drug tests?](https://ontology.bommaritollc.com/id/01a0ee02-5bb4-702a-8500-82be1cde83ae)
  - [49 CFR 40.93 What validity tests must laboratories conduct on primary oral fluid specimens?](https://ontology.bommaritollc.com/id/01a0ee02-5bb5-72f4-af4e-236060676852)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title49-vol1](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0ee02-a4d6-748b-bd3b-8d128b7da622)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0ee05-8cd5-74e3-b6bd-9ad2ccdd5ef4)
  - [evidence from https://www.govinfo.gov/link/cfr/49/40?sectionnum=177&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f18-2b0d-7629-b45a-d7faf7abd645)
- `schema:isPartOf`: [49 CFR Part 40, Subpart H—Split Specimen Tests](https://ontology.bommaritollc.com/id/01a0ee02-0928-7725-aab6-beebeb4a8fc8)
- `schema:legislationIdentifier`: 49 CFR 40.177
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?
- `schema:url`: [https://www.govinfo.gov/link/cfr/49/40?sectionnum=177&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/49/40?sectionnum=177&year=mostrecent&link-type=details)
- `skos:prefLabel`: 49 CFR 40.177 What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/49/40?sectionnum=177&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title49-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5.nt), [HTML](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5)
Cite as: 49 CFR 40.177 What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
